Literature DB >> 21432171

Sensitive pupil response of early-onset alzheimer's patients to a dilute mixture of cholinergic antagonist and α-Adrenergic stimulant.

A Takagi1, M Miyao, S Ishihara, H Sakakibara, T Kondo, H Toyoshima, K Kono, A Iguchi.   

Abstract

To investigate possible differences in pupil dilation and light reflex in Alzheimer's disease patients that can be attributed to the age of onset of the disease, a statistical comparison was made of pupil dilation and light reflex among early- and late-onset Alzheimer's disease, Down syndrome, and patients with vascular dementia, and normal controls. The subjects included 53 probable Alzheimer's disease outpatients, including both early-onset type (AD: n=21) and late-onset type (SD: n=32). They were compared with normal controls (n=15), Down syndrome patients (DS: n=6), and patients with vascular dementia (VD: n=9). All subjects and controls were dark-eyed Japanese. Pupil dilation and light reflex were tested in 21 AD and 32 SD patients, and were compared with those in the control subjects; 6 DS and 9 VD patients. The measured maximum increase in pupil diameter after instilling a mixture of anticholinergic and α -adrenergic stimulating drugs (Midrin-P®), in one eye was significantly greater in AD and DS than in the controls. However, there was no difference among SD, VD, and controls, suggesting a stronger pupil response to these drugs in AD than in SD. Pupil movement in response to light became significantly smaller and faster after instillation of the drugs in Alzheimer's disease patients. The above findings may be useful for the early detection of Alzheimer's disease.

Entities:  

Keywords:  Alzheimer’s disease; Down syndrome; light reflex; pupil; tropicamide

Year:  1999        PMID: 21432171      PMCID: PMC2723423          DOI: 10.1007/BF02931250

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  19 in total

1.  Atropine response of the eyes in mongolism.

Authors:  J H PRIEST
Journal:  Am J Dis Child       Date:  1960-12

2.  Atropine in mongolism.

Authors:  J M BERG; M W BRANDON; B H KIRMAN
Journal:  Lancet       Date:  1959-09-26       Impact factor: 79.321

Review 3.  Review and hypothesis: Alzheimer disease and Down syndrome--chromosome 21 nondisjunction may underlie both disorders.

Authors:  H Potter
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

4.  Pupillometric evaluation and analysis of light reflex in healthy subjects as a tool to study autonomic nervous system changes with aging.

Authors:  G Pozzessere; E Valle; P Rossi; B Petrucci; A Ambrosini; M D'Alessio; F Pierelli; P Giacomini
Journal:  Aging (Milano)       Date:  1996-02

5.  Presenile dementia associated with mosaic trisomy 21 in a patient with a Down syndrome child.

Authors:  J Hardy; A Goate; M Owen; M Rossor
Journal:  Lancet       Date:  1989-09-23       Impact factor: 79.321

6.  Detecting Alzheimer's disease.

Authors:  A Treloar; M Assin; A Macdonald
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728

7.  Pupil dilation to tropicamide is not specific for Alzheimer disease.

Authors:  J H Growdon; K Graefe; M Tennis; D Hayden; D Schoenfeld; S H Wray
Journal:  Arch Neurol       Date:  1997-07

8.  Factors affecting light-adapted pupil size in normal human subjects.

Authors:  B Winn; D Whitaker; D B Elliott; N J Phillips
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-03       Impact factor: 4.799

9.  Do women and myopes have larger pupils?

Authors:  R Jones
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-07       Impact factor: 4.799

Review 10.  The neurobiologic consequences of Down syndrome.

Authors:  J T Coyle; M L Oster-Granite; J D Gearhart
Journal:  Brain Res Bull       Date:  1986-06       Impact factor: 4.077

View more
  1 in total

1.  Infrared Video Pupillography Coupled with Smart Phone LED for Measurement of Pupillary Light Reflex.

Authors:  Lily Yu-Li Chang; Jason Turuwhenua; Tian Yuan Qu; Joanna M Black; Monica L Acosta
Journal:  Front Integr Neurosci       Date:  2017-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.